Portage Biotech Inc. (PRTG)
Portage Biotech Statistics
Share Statistics
Portage Biotech has 1.12M shares outstanding. The number of shares has increased by -94.33% in one year.
| Shares Outstanding | 1.12M |
| Shares Change (YoY) | -94.33% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | 10.71% |
| Shares Floating | 275.06K |
| Failed to Deliver (FTD) Shares | 111.71K |
| FTD / Avg. Volume | 8.93% |
Short Selling Information
The latest short interest is 308.41K, so 18.74% of the outstanding shares have been sold short.
| Short Interest | 308.41K |
| Short % of Shares Out | 18.74% |
| Short % of Float | 23.67% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -2.99 and the forward PE ratio is -0.87. Portage Biotech's PEG ratio is 0.07.
| PE Ratio | -2.99 |
| Forward PE | -0.87 |
| PS Ratio | 0 |
| Forward PS | 4.2 |
| PB Ratio | 55.93 |
| P/FCF Ratio | -15.74 |
| PEG Ratio | 0.07 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Portage Biotech.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.67 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0 |
| Debt / FCF | 0 |
| Interest Coverage | -570.41 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-10.76M |
| Employee Count | 7 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -10.55M |
| Effective Tax Rate | 12.31% |
Stock Price Statistics
The stock price has increased by 95.99% in the last 52 weeks. The beta is 0.97, so Portage Biotech's price volatility has been higher than the market average.
| Beta | 0.97 |
| 52-Week Price Change | 95.99% |
| 50-Day Moving Average | 5.59 |
| 200-Day Moving Average | 4.95 |
| Relative Strength Index (RSI) | 61.61 |
| Average Volume (20 Days) | 1.25M |
Income Statement
| Revenue | n/a |
| Gross Profit | -54K |
| Operating Income | -18.25M |
| Net Income | -75.34M |
| EBITDA | -18.2M |
| EBIT | -18.25M |
| Earnings Per Share (EPS) | -3.7 |
Balance Sheet
The company has 5.03M in cash and 47K in debt, giving a net cash position of 4.98M.
| Cash & Cash Equivalents | 5.03M |
| Total Debt | 47K |
| Net Cash | 4.98M |
| Retained Earnings | -239.32M |
| Total Assets | 2.71M |
| Working Capital | 1.81M |
Cash Flow
In the last 12 months, operating cash flow was -14.3M and capital expenditures 0, giving a free cash flow of -14.3M.
| Operating Cash Flow | -14.3M |
| Capital Expenditures | 0 |
| Free Cash Flow | -14.3M |
| FCF Per Share | -0.7 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
PRTG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for PRTG.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Aug 15, 2024. It was a backward split with a ratio of 1:20.
| Last Split Date | Aug 15, 2024 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -216.5 |
| Piotroski F-Score | 3 |